A very recently published open-label extension study by Stahl et al. [ 414] observed small changes in PRL levels.
8, 28 The pivotal fracture trial for denosumab described earlier is being followed by a longer-term extension study.
44 The effect of long-term dapoxetine treatment on satisfaction with sexual intercourse was examined in the nonrandomized extension study by Steidle et al (see Table 3).
The randomized trial was followed by a 6-month extension study in which CGM was initiated in the control group and continued in the CGM group.
Twelve patients were enrolled in a randomized, double-blind, placebo-controlled trial of idursulfase for 24 weeks, followed by an open-label extension study.
Treatment compliance in elderly patients was reported in an extension study by Stender et al. 22 Compliance, defined as taking between 80%–120% of the prescribed treatment regimen, was achieved in 97.5% of the 60-month follow-up population.
In an open-label extension study by Kremer et al, 20 RA patients with MTX-IR treated with ETN+MTX were permitted dose reductions for MTX or, in some cases, corticosteroid after at least 3 months of combination therapy.
In summary, more detailed safety data addressing the infectiological, immunological, neoplastic, cardiovascular and hepatic implications of TOZ treatment have to be gathered by upcoming extension studies.
The long-lasting relief of pain in this case was surprising, but the potential for this outcome was suggested by a previous 1-year extension study [17].
Information on patients receiving adalimumab therapy was obtained from an open-label extension study conducted by Abbott Laboratories (study DE033).
